Prescription drug · ANDA
Hydrocodone Bitartrate and Acetaminophen NDC 64950-373
Hydrocodone bitartrate 7.5 mg/15mL; Acetaminophen 325 mg/15mL · Solution · Oral · Genus Lifesciences Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 64950-373-04 | 64950037304 | 4 mL in 1 BOTTLE (64950-373-04)Marketed from Oct 15, 2023 | |
| 64950-373-16 | 64950037316 | 473 mL in 1 BOTTLE (64950-373-16)Marketed from Oct 15, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Hydrocodone Bitartrate and Acetaminophen
- Generic name (nonproprietary)
- hydrocodone bitartrate and acetaminophen
- Active ingredients
- Hydrocodone bitartrate — 7.5 mg/15mLAcetaminophen — 325 mg/15mL
- Dosage form
- Solution
- Route
- Oral
- Labeler
- Genus Lifesciences Inc.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 040838
- Marketing start
- Listing expires
- DEA schedule
- CII
- Other FDA classes
- Opioid Agonists (Mechanism)
- Identifiers
- Product ID 64950-373_fa4d198c-5525-42d1-adea-04dcc863788dSPL ID fa4d198c-5525-42d1-adea-04dcc863788dSPL set ID a9fb9779-76a5-407a-a155-84f198004ae2RxCUI 856940UNII NO70W886KK, 362O9ITL9D
- Pharmacologic class
- Opioid Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N464950037304followed by a unit qualifier and the quantityPackage 64950-0373-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Hydrocodone Bitartrate and Acetaminophen Oral Solution is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse, with opioids, which can occur at any dosage or duration [see WARNINGS ], reserve Hydrocodone Bitartrate and Acetaminophen Oral Solution for use in patients for whom alternative treatment options (e.g., non-opioid analgesics): Have not been tolerated or are not expected to be tolerated, Have not provided adequate analgesia or are not expected to provide adequate analgesia Hydrocodone Bitartrate and Acetaminoph…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 040838
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Hydrocodone Bitartrate and Acetaminophen | Hydrocodone bitartrate 7.5 mg/15mL; Acetaminophen 325 mg/15mL | SolutionOral | PAI Holdings, LLC dba PAI Pharma | 0121-2316 |
| Hydrocodone Bitartrate and Acetaminophen | Hydrocodone bitartrate 7.5 mg/15mL; Acetaminophen 325 mg/15mL | SolutionOral | Redpharm drug | 67296-2093 |
| Hydrocodone Bitartrate and Acetaminophen | Hydrocodone bitartrate 2.5 mg/5mL; Acetaminophen 108 mg/5mL | SolutionOral | PAI Holdings, LLC dba PAI Pharma | 0121-4772 |
| Hydrocodone Bitartrate and Acetaminophen | Hydrocodone bitartrate 5 mg/10mL; Acetaminophen 217 mg/10mL | SolutionOral | PAI Holdings, LLC dba PAI Pharma | 0121-1544 |